{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:54:49Z","timestamp":1782964489506,"version":"3.54.5"},"reference-count":314,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2020.00086","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T04:25:40Z","timestamp":1590726340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability"],"prefix":"10.3389","volume":"13","author":[{"given":"Masaharu","family":"Takamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/mcne.2000.0834","article-title":"Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle","volume":"15","author":"Akaaboune","year":"2000","journal-title":"Mol. Cell Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1523\/JNEUROSCI.1375-16.2017","article-title":"Cortactin is a regulator of activity-dependent synaptic plasticity controlled by Wingless","volume":"37","author":"Alicea","year":"2017","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"203536","DOI":"10.1155\/2012\/203536","article-title":"Intracellular Ca2+ stores and Ca2+ influx are both required for BDNF to rapidly increase quantal vesicular transmitter release","volume":"2012","author":"Amaral","year":"2012","journal-title":"Neural Plast."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1523\/JNEUROSCI.4610-11.2012","article-title":"Biglycan is an extracellular MuSK binding protein important for synaptic stability","volume":"32","author":"Amenta","year":"2012","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2169\/internalmedicine.3828-19","article-title":"A case of anti-Lrp4 antibody-associated myasthenia gravis with a rare complication of thymoma successfully treated by thymectomy","volume":"59","author":"Aoki","year":"2020","journal-title":"Intern. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbrc.2020.02.027","article-title":"1\u03b1, 25(OH)2D3 regulates agrin-induced acetylcholine receptor clustering through upregulation of rapsyn expression in C2C12 myotubes","volume":"525","author":"Arakawa","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jclinpath-2017-204788","article-title":"PD-1 and PD-L1 expression in thymic epithelial tumours and non-neoplastic thymus","volume":"71","author":"Bagir","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"","journal-title":"J. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/dneu.22190","article-title":"Crosstalk between agrin and Wnt signaling in development of vertebrate neuromuscular junction","volume":"74","author":"Barik","year":"","journal-title":"Dev. Neurobiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2015.10.006","article-title":"\u03b2-adrenoceptor agonists as novel, safe and potentially effective therapies for amyotrophic lateral sclerosis (ALS)","volume":"85","author":"Bartus","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1523\/JNEUROSCI.4201-06.2007","article-title":"Potentiation of exocytosis by phospholipase C-coupled G-protein-coupled receptors requires the priming protein Munc13\u20131","volume":"27","author":"Bauer","year":"2007","journal-title":"J. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"24035","DOI":"10.1074\/jbc.m109.014266","article-title":"Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors","volume":"284","author":"Bavelova","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/CJI.0000000000000278","article-title":"Myasthenia gravis induced by immune checkpoint inhibitors","volume":"42","author":"Becquart","year":"2019","journal-title":"J. Immunother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40265-019-1065-0","article-title":"Therapeutic directed against B-cells and downstream effects in generalized autoimmune myasthenia gravis: current status","volume":"79","author":"Beecher","year":"2019","journal-title":"Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/WCO.0000000000000370","article-title":"Congenital myasthenic syndromes: recent advances","volume":"29","author":"Beeson","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/nyas.13576","article-title":"Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway","volume":"1413","author":"Beeson","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/jnd-170294","article-title":"New pathway and therapeutic targets in autoimmune myasthenia gravis","volume":"5","author":"Behin","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"134833","DOI":"10.1016\/j.neulet.2020.134833","article-title":"The role of the dystrophin glycoprotein complex on the neuromuscular system","volume":"722","author":"Belhasan","year":"2020","journal-title":"Neurosci. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e53826","DOI":"10.1371\/journal.pone.0053826","article-title":"A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia","volume":"8","author":"Ben Ammar","year":"2013","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol. Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a complrehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrm1074","article-title":"New insight into the roles of agrin","volume":"4","author":"Bezakova","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cophys.2018.07.002","article-title":"Regulation of mammalian neuromuscular junction formation and maintenance by Wnt signaling","volume":"4","author":"Bo\u00ebx","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nmd.2015.01.012","article-title":"A critical and previously unsuspected role for doublecortin at the neuromuscular junction in mouse and human","volume":"25","author":"Bourgeois","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.conb.2010.12.002","article-title":"Wnt signaling during synaptic development and plasticity","volume":"21","author":"Budnik","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"E490","DOI":"10.3390\/ijms19020490","article-title":"Fundamental molecules and mechanisms for forming and maintaining neuromuscular synapses","volume":"19","author":"Burden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e009167","DOI":"10.1101\/cshperspect.a009167","article-title":"The role of MuSK in synapse formation and neuromuscular disease","volume":"5","author":"Burden","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0896-6273(00)80751-5","article-title":"Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction","volume":"23","author":"Burgess","year":"1999","journal-title":"Neuron"},{"key":"B29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.nmd.2012.11.004","article-title":"Sulbutamol benefits children with congenital myasthenic syndrome due to DOk7 mutations","volume":"23","author":"Burke","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.mod.2012.11.001","article-title":"Roles of the amyloid precursor protein family in the peripheral nervous system","volume":"130","author":"Caldwell","year":"2013","journal-title":"Mech. Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1471-4159.2010.06965.x","article-title":"Presynaptic calcium channels and \u03b13-integrins are complexed with synaptic cleft laminins, cytoskeletal elements and active zone components","volume":"115","author":"Carson","year":"2010","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"Cartaud","year":"2004","journal-title":"J. Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0038-1660500","article-title":"Pathogenic mechanisms and clinical correlations in autoimmune myasthenic syndromes","volume":"38","author":"Cetin","year":"2018","journal-title":"Semin. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/jnnp-2019-322640","article-title":"Myasthenia gravis AChR antibodies inhibit function of rapsyn-cluster AChRs","volume":"91","author":"Cetin","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1523\/JNEUROSCI.3771-10.2011","article-title":"Calcium channels link the muscle-derived synapse organizer laminin \u03b22 to Bassoon and CAST\/Erc2 to organize presynaptic active zones","volume":"31","author":"Chen","year":"2011","journal-title":"J. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1523\/JNEUROSCI.3226-13.2014","article-title":"Coronin 6 regulates acetylcholine receptor clustering through modulating receptor anchorage to actin cytoskeleton","volume":"34","author":"Chen","year":"2014","journal-title":"J. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuron.2007.06.031","article-title":"Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction","volume":"55","author":"Chen","year":"2007","journal-title":"Neuron"},{"key":"B38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mus.23882","article-title":"Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?","volume":"49","author":"Choi Decroos","year":"2014","journal-title":"Muscle Nerve"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.4110\/in.2020.20.e9","article-title":"Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors","volume":"20","author":"Choi","year":"2020","journal-title":"Immune Netw."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e00220","DOI":"10.7554\/eLife.00220","article-title":"APP interacts with Lrp4 and agrin to coordinate the development of the neuromuscular junction in mice","volume":"2","author":"Choi","year":"2013","journal-title":"Elife"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e58441","DOI":"10.1371\/journal.pone.0058441","article-title":"BMP4 is a peripherally-derived factor for motor neurons and attenuates glutamate-induced excitotoxicity in vitro","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"134822","DOI":"10.1016\/j.neulet.2020.134822","article-title":"MMP-mediated modulation of ECM environment during axonal growth and NMJ development","volume":"724","author":"Chan","year":"2020","journal-title":"Neurosci. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve"},{"key":"B45","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann. Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbamem.2013.08.023","article-title":"Dystrophin complex functions as a scaffold for signaling proteins","volume":"1838","author":"Constantin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00415-017-8514-z","article-title":"Screening for lipoprotein receptor-protein 4-, agrin- and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis","volume":"264","author":"Cordts","year":"2017","journal-title":"J. Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cort\u00e9s-Vicente","year":"2016","journal-title":"JAMA Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/1756285615605700","article-title":"Future perspectives in target-specific immunotherapies of myasthenia gravis","volume":"8","author":"Dalakas","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1756286418799864","DOI":"10.1177\/1756286418799864","article-title":"Neurological complications of immune checkpoint inhibitors: what happens when you \u2018take the brakes off\u2019 the immune system","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41582-018-0110-z","article-title":"Immunotherapy in myasthenia gravis in the era of biologics","volume":"15","author":"Dalakas","year":"2019","journal-title":"Nat. Rev. Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jnnp-2019-322606","article-title":"Rituximab in AChR subtype of myasthenia gravis: systematic review","volume":"91","author":"Di Stefano","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"D\u00edaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"B3040","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1056\/NEJM19820.9233071.301","article-title":"Functional activities of antibodies to acetylcholine receptors and clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/nejm197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.25708","article-title":"Severe neurological toxicity in immune checkpoint inhibitors: growing spectrum","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann. Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00415-019-09239-7","article-title":"Congenital myasthenic syndrome caused by novel COL13A1 mutations","volume":"266","author":"Dusl","year":"2019","journal-title":"J. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbrc.2019.12.011","article-title":"Overespression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission","volume":"523","author":"Eguchi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"144","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann. N Y Acad. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Dianosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1111\/febs.12145","article-title":"Biological interplay between proteoglycans and their innate immune receptors in inflammation","volume":"280","author":"Frey","year":"2013","journal-title":"FEBS J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3389\/fimmu.2019.03052","article-title":"Antagonism of the neonatal Fc receptor as an emerging treatment for myasthenia gravis","volume":"10","author":"Gable","year":"2020","journal-title":"Front. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.autrev.2014.08.039","article-title":"Cortactin autoantibodies in myasthenia gravis","volume":"13","author":"Gallardo","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.nmd.2013.08.002","article-title":"Salbutamol-responsive limb-girdle congenital myasthenic syndome due to a novel missense mutation and heteroallelic deletion in MuSK","volume":"24","author":"Gallenmller","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.128.4.625","article-title":"Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active state","volume":"128","author":"Gesemann","year":"1995","journal-title":"J. Cell Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle specific kinase: organizer of synaptic membrane domains","volume":"43","author":"Ghazanfari","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e87840","DOI":"10.1371\/journal.pone.0087840","article-title":"Effects of the \u03b22-adrenoceptor agonist, alubuterol, in a mouse model of anti-MuSK myasthenia gravis","volume":"9","author":"Ghazanfari","year":"2014","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.ajpath.2016.05.025","article-title":"Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis","volume":"186","author":"Gomez","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4049\/jimmunol.1301555","article-title":"Proteasome inhibition with bortezomid depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients","volume":"193","author":"Gomez","year":"2014","journal-title":"J. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1242\/dev.071555","article-title":"Initiation of synapse formation by Wnt-induced MuSK endocytosis","volume":"139","author":"Gordon","year":"2012","journal-title":"Development"},{"key":"B76","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fmolb.2019.00156","article-title":"Dissecting the extracellular complexity of neuromuscular junction organizers","volume":"6","author":"Guarino","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"B78","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbadis.2014.11.022","article-title":"Myasthenia gravis and related disorders: pathology and molecular pathogenesis","volume":"1852","author":"Ha","year":"2015","journal-title":"Biochem. Biophys. Acta"},{"key":"B79","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1128\/mcb.00775-15","article-title":"Sorbs1 and -2 interact with CrkL and are required for acetylcholine receptor cluster formation","volume":"36","author":"Hallock","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1101\/gad.1977710","article-title":"Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L","volume":"24","author":"Hallock","year":"2010","journal-title":"Genes Dev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1534\/genetics.115.176529","article-title":"Transmission, development, and plasticity of synapses","volume":"201","author":"Harris","year":"2015","journal-title":"Genetics"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ar.24092","article-title":"Collagen XIII and other ECM components in the assembly and disease of the neuromuscular junction","author":"Heikkinen","year":"2019","journal-title":"Anat. Rec."},{"key":"B83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000322737","article-title":"Matrix metalloproteinases in myasthenia gravis","volume":"65","author":"Helgeland","year":"2011","journal-title":"Eur. Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.3390\/ijms12128924","article-title":"The Wnt and BMP families of signaling morphogens at the vertebrate neuromuscular junction","volume":"12","author":"Henr\u00edquez","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1748-1716.2011.02295.x","article-title":"Dual roles for Wnt signaling during the formation of the vertebrate neuromuscular junction","volume":"204","author":"Henriquez","year":"2012","journal-title":"Acta Physiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"18812","DOI":"10.1073\/pnas.0806300105","article-title":"Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin","volume":"105","author":"Henriquez","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B87","doi-asserted-by":"publisher","first-page":"134676","DOI":"10.1016\/j.neulet.2019.134676","article-title":"MuSK function during health and disease","volume":"716","author":"Herbst","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e88739","DOI":"10.1371\/journal.pone.0088739","article-title":"Injection of soluble fragment of neural agrin (N-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction","volume":"9","author":"Hettwer","year":"2014","journal-title":"PLoS One"},{"key":"B89","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1091\/mbc.e09-05-0381","article-title":"Caveolin-3 promotes nicotinic acetylcholine receptor clustering and regulates neuromuscular junction activity","volume":"21","author":"Hezel","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/j.1460-2075.1994.tb06575.x","article-title":"Structural domains of agrin required for clustering of nicotinic acetylcholine receptors","volume":"13","author":"Hoch","year":"1994","journal-title":"EMBO J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4161\/cam.21831","article-title":"Laminins in basement membrane assembly","volume":"7","author":"Hochenester","year":"2013","journal-title":"Cell Adh. Migr."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.febslet.2013.10.001","article-title":"Mesdc2 plays a key role in cell-surface expression of Lrp4 and postsynaptic specialization in myotubes","volume":"587","author":"Hoshi","year":"2013","journal-title":"FEBS Lett."},{"key":"B95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e2661","DOI":"10.1212\/wnl.0000000000007600","article-title":"Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis","volume":"92","author":"Howard","year":"2019","journal-title":"Neurology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.5125","article-title":"Clinical effects of the self-administered subcutaneous complement inhibitor Zilucoplan in patients with moderate to severe generalized myasthenia gravis: results of a phase 2 randomized double-blind, placebo-controlled, multicenter clinical trial","author":"Howard","year":"2020","journal-title":"JAMA Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/ejn.14346","article-title":"Correct expression and localization of collagen XIII are crucial for the normal formation and function of the neuromuscular system","volume":"49","author":"H\u00e4r\u00f6nen","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/hmg\/ddx101","article-title":"Collagen XIII secures pre- and postsynaptic integrity of the neuromuscular synapse","volume":"26","author":"H\u00e4r\u00f6nen","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B100","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fimmu.2020.00240","article-title":"New approaches to targeting B cells for myasthenia gravis","volume":"11","author":"Huda","year":"2020","journal-title":"Front. Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1212\/nxi.0000000000000645","article-title":"SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody","volume":"7","author":"Huda","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/nxi.0000000000000357","article-title":"IgG-specific cell-based assay detected potentially pathogenic MuSK-abs in seronegative MG","volume":"4","author":"Huda","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2019.03.001","article-title":"Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis","volume":"317","author":"Huijbers","year":"","journal-title":"Exp. Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1212\/nxi.0000000000000547","article-title":"MuSK myasthenia gravis monoclonal antibodies: valency dictates pathogenicity","volume":"6","author":"Huijbers","year":"","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2015.12.016","article-title":"Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity","volume":"291","author":"Huijbers","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B107","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fnmol.2017.00147","article-title":"Muscle contraction regulates BDNF\/TrkB signaling to modulate synaptic function through presynaptic cPKC\u03b1 and cPKC\u03b2I","volume":"10","author":"Hurtado","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.13502","article-title":"Dioagnostic utility of cortactin antibodies in myasthenia gravis","volume":"1412","author":"Illa","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"ra7","DOI":"10.1126\/scisignal.2000113","article-title":"Dok-7 activates the muscle receptor kinase MuSK and shapes synaptic formation","volume":"2","author":"Inoue","year":"2009","journal-title":"Sci. Signal."},{"key":"B110","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.matbio.2018.02.014","article-title":"Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations","author":"Ito","year":"2018","journal-title":"Matrix Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jneuroim.2016.10.011","article-title":"Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis","volume":"301","author":"Iwasa","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/(sici)1097-4598(199812)21:12<1655::aid-mus5>3.0.co;2-f","article-title":"Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies","volume":"21","author":"Iwasa","year":"1998","journal-title":"Muscle Nerve"},{"key":"B113","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2018.09.012","article-title":"Programmed cell death ligand 1 expression is upregulated in the skeletal muscle of patients with myasthenia gravis","volume":"325","author":"Iwasa","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.neuron.2008.12.025","article-title":"Wnt signals organize synaptic prepattern and axon guidance through the Zebrafish unplugged\/MuSK receptor","volume":"61","author":"Jing","year":"2009","journal-title":"Neuron"},{"key":"B115","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1212\/wnl.0000000000007235","article-title":"Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: systemic review","volume":"92","author":"Johansen","year":"2019","journal-title":"Neuerology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cbi.2012.10.006","article-title":"Developmental consequences of the ColQ\/MuSK interactions","volume":"203","author":"Karmouch","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"32035","DOI":"10.1074\/jbc.m500429200","article-title":"Activation of M1 muscarinic acetylcholine receptors stimulates the formation of multiprotein complex centered on TRPC6 channels","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"B121","doi-asserted-by":"publisher","first-page":"a008045","DOI":"10.1101\/cshperspect.a008045","article-title":"Wnt signaling in neuromuscular junction development","volume":"4","author":"Koles","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"16820","DOI":"10.1074\/jbc.m112.342667","article-title":"Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons","volume":"287","author":"Koles","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2018.00097","article-title":"A new classification systemfor IgG4 autoantibodies","volume":"9","author":"Koneczny","year":"2018","journal-title":"Front. Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/joa.12034","article-title":"The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis","volume":"224","author":"Koneczny","year":"2014","journal-title":"J. Anat."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of Lrp4 with MuSK but both IgG4 and IgG1\u20133 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cells"},{"key":"B127","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnsyn.2016.00005","article-title":"Molecular machines regulating the release probability of synaptic vesicles at the active zone","volume":"8","author":"K\u00f6rber","year":"2016","journal-title":"Front. Synaptic Neurosci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","article-title":"A comprehensive review on the role of co-signalling receptors and Treg homeostasis in autoimmunity and tumor immunity","volume":"95","author":"Kumar","year":"2018","journal-title":"J. Autoimmun."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.01.006","article-title":"Cancer immunotherapy with ckeck point inhibitor can cause autoimmune adverse events due to loss of Treg","author":"Kumar","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/mus.24057","article-title":"Targeting therapy to the neuromuscular junction: proof of concept","volume":"49","author":"Kusner","year":"2014","journal-title":"Muscle Nerve"},{"key":"B132","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.omtm.2019.04.009","article-title":"Investigational RNAi therapeutic targeting C5 is efficacious in pre-clinical models of myasthenia gravis","volume":"13","author":"Kusner","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1212\/wnl.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in Dok7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"12230","DOI":"10.1523\/JNEUROSCI.5518-09.2010","article-title":"Muscle-derived collagen XIII regulates maturation of the skeletal neuromuscular junction","volume":"30","author":"Latvanlehto","year":"2010","journal-title":"J. Neurosci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"577136","DOI":"10.1016\/j.jneuroim.2019.577136","article-title":"Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis","volume":"339","author":"Lazaridis","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Antibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuroscience.2009.05.057","article-title":"Rapsyn interacts with the muscle acetylcholine receptor via \u03b1-helical domains in the \u03b1, \u03b2, and \u03b5 subunit intracellular loops","volume":"163","author":"Lee","year":"2009","journal-title":"Neuroscience"},{"key":"B138","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.14028","article-title":"Moving forward with the neuromuscular junction","volume":"142","author":"Legay","year":"2017","journal-title":"J. Neurochem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann. Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.neuron.2016.10.023","article-title":"Enzymatic activity of the scaffold protein rapsyn for synapse formation","volume":"92","author":"Li","year":"2016","journal-title":"Neuron"},{"key":"B142","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nn2053","article-title":"Retrograde regulation of motoneuron differentiation by muscle-\u03b2-catenin","volume":"11","author":"Li","year":"2008","journal-title":"Nat. Neurosci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.expneurol.2018.11.006","article-title":"Tacrolimus inhibits Th1 and Th12 responses in MuSK-antibody positive myasthenia gravis patients","volume":"312","author":"Li","year":"2019","journal-title":"Exp. Neurol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/mus.26025","article-title":"Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis","volume":"57","author":"Li","year":"2018","journal-title":"Muscle Nerve"},{"key":"B140","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-physiol-022516-034255","article-title":"Neuromuscular junction formation, aging, and disorders","volume":"80","author":"Li","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/mus.25591","article-title":"Anti-Lrp4 autoantibodies in chinese patients with myasthenia gravis","volume":"56","author":"Li","year":"2017","journal-title":"Muscle Nerve"},{"key":"B146","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of Albuterol in congenital endplate acetylcholinesterase deficiency and DOK-7 myasthenia","volume":"44","author":"Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"key":"B147","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.neuron.2005.04.002","article-title":"Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism","volume":"46","author":"Lin","year":"2005","journal-title":"Neuron"},{"key":"B148","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.neuron.2008.09.025","article-title":"A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates agrin signaling at the neuromuscular junction","volume":"60","author":"Linnoila","year":"2008","journal-title":"Neuron"},{"key":"B149","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nmd.2016.11.009","article-title":"Ephedrine treatment for autoimmune myasthenia gravis","volume":"27","author":"Lipka","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"B150","doi-asserted-by":"publisher","first-page":"116690","DOI":"10.1016\/j.jns.2020.116690","article-title":"Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study","volume":"411","author":"Litchman","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/eji.200939792","article-title":"Expansion of regulatory T cells via IL-2\/anti-IL-2 mAb complexes suppresses experimental myasthenia","volume":"40","author":"Liu","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ajhg.2015.10.017","article-title":"Congenital myasthenic syndrome type 19 is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII \u03b11 chain","volume":"97","author":"Logan","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"B153","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jns.2013.05.017","article-title":"Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation","volume":"331","author":"Lorenzoni","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/brain\/awh612","article-title":"Increased expression of rapsyn in muscle prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis","volume":"128","author":"Losen","year":"2005","journal-title":"Brain"},{"key":"B155","doi-asserted-by":"publisher","first-page":"151258","DOI":"10.4061\/2011\/151258","article-title":"Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls","volume":"2011","author":"Luckman","year":"2011","journal-title":"Autoimmune Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s0896-6273(02)00783-3","article-title":"Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1","volume":"35","author":"Luo","year":"2002","journal-title":"Neuron"},{"key":"B156","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuron.2008.08.013","article-title":"HSP90 \u03b2 regulates rapsyn turnover and subsequent AChR cluster formation and maintenance","volume":"60","author":"Luo","year":"2008","journal-title":"Neuron"},{"key":"B158","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1152\/jn.00198.2014","article-title":"New insights into short-term synaptic facilitation at the frog neuromuscular junction","volume":"113","author":"Ma","year":"2015","journal-title":"J. Neurophysiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e8478","DOI":"10.1371\/journal.pone.0008478","article-title":"The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction","volume":"4","author":"Madhavan","year":"2009","journal-title":"PLoS One"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e0135378","DOI":"10.1371\/journal.pone.0135378","article-title":"Flow cytofluorimetric analysis of anti-Lrp4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis","volume":"10","author":"Marino","year":"2015","journal-title":"PLoS One"},{"key":"B161","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction","volume":"19","author":"Maselli","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B163","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.2012.06807.x","article-title":"Synaptic basal lamina-associated congenital myasthenic syndrome","volume":"1275","author":"Maselli","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1093\/hmg\/ddz059","article-title":"Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome","volume":"28","author":"McMacken","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B166","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1523\/JNEUROSCI.3381-14.2015","article-title":"MuSK Frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance","volume":"35","author":"Mess\u00e9ant","year":"2015","journal-title":"J. Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1242\/dev.146167","article-title":"Wnt proteins contribute to neuromuscular junction formation through distinct signaling pathways","volume":"144","author":"Mess\u00e9ant","year":"2017","journal-title":"Development"},{"key":"B168","doi-asserted-by":"publisher","first-page":"E1777","DOI":"10.3390\/jcm8111777","article-title":"Neurological immune related adverse events associated with Nivolumab, Ipilimumab, and pembrolizumab therapy-review of the literature and future outlook","volume":"8","author":"M\u00f6hn","year":"2019","journal-title":"J. Clin. Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"11547","DOI":"10.1523\/JNEUROSCI.4396-10.2011","article-title":"Nestin is not essential for development of the CNS but required for dispersion of acetylcholine receptor clusters at the area of neuromuscular junctions","volume":"31","author":"Mohseni","year":"2011","journal-title":"J. Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"39716","DOI":"10.1038\/srep39716","article-title":"Profile of upregulated inflammatory proteins in sera of myasthenia gravis patients","volume":"7","author":"Molin","year":"2017","journal-title":"Sci. Rep."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1038\/srep39716","article-title":"Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation","volume":"11","author":"Moreth","year":"2012","journal-title":"Cell Cycle"},{"key":"B172","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am. J. Pathol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with Lrp4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp. Neurol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mus.26107","article-title":"Myasthenia gravis with musk-specific tyrosine kinase antibodies: a narrative review","volume":"58","author":"Morren","year":"2018","journal-title":"Muscle Nerve"},{"key":"B175","doi-asserted-by":"publisher","first-page":"116648","DOI":"10.1016\/j.jns.2019.116648","article-title":"Maintenance immunosuppression in myasthenia gravis, an update","volume":"410","author":"Morren","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B176","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve"},{"key":"B177","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.410320419","article-title":"Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma","volume":"32","author":"Mygland","year":"1992","journal-title":"Ann. Neurol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13041-016-0248-9","article-title":"Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction","volume":"9","author":"Nadal","year":"2016","journal-title":"Mol. Brain"},{"key":"B179","doi-asserted-by":"publisher","first-page":"28512","DOI":"10.1038\/srep28512","article-title":"R-spondin 2 promotes acetylcholine receptor clustering at the neuromuscular junction via Lgr 5","volume":"6","author":"Nakashima","year":"2016","journal-title":"Sci. Rep."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/ene.12169","article-title":"Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis","volume":"20","author":"Nakata","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1369\/0022155412456380","article-title":"Biglycan: a multivalent proteoglycan providing structure and signals","volume":"60","author":"Nastase","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"B182","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1242\/jcs.095109","article-title":"Neuregulin-1 potentiates agrin-induced acetylcholine receptor clustering through muscle-specific kinase phosphorylation","volume":"125","author":"Ngo","year":"2012","journal-title":"J. Cell Sci."},{"key":"B2951","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/brain\/awu160","article-title":"Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy","volume":"137","author":"Nicole","year":"2014","journal-title":"Brain"},{"key":"B184","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-011-8216-y","article-title":"Molecular mechanism of active zone organization at vertebrate neuromuscular junctions","volume":"45","author":"Nishimune","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1083\/jcb.200805095","article-title":"Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction","volume":"182","author":"Nishimune","year":"2008","journal-title":"J. Cell Biol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"Lrp4 third \u03b2-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis","volume":"312","author":"Okada","year":"2006","journal-title":"Science"},{"key":"B189","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1113\/jphysiol.2004.067595","article-title":"Tetanic depression is overcome by tonic adenosine A2A receptor facilitation of L-type Ca2+ influx into rat motor nerve terminals","volume":"560","author":"Oliverira","year":"2004","journal-title":"J. Physiol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fncel.2014.00453","article-title":"Bone morphogenetic protein signaling in vertebrate motor neurons and neuromuscular communication","volume":"8","author":"Osses","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"13928","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/Lrp4\/MuSK signaling","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci. Rep."},{"key":"B192","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a US experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e43669","DOI":"10.1371\/journal.pone.0043669","article-title":"Site specific cleavage mediated by MMPs regulates function of agrin","volume":"7","author":"Patel","year":"2012","journal-title":"PLoS One"},{"key":"B194","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1023\/a:1018545827369","article-title":"Association of cortactin with developing neuromuscular specializations","volume":"26","author":"Peng","year":"1997","journal-title":"J. Neurocytol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2011","journal-title":"J. Neurol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-009-8089-5","article-title":"The roles of the dystrophin-associated glycoprotein complex at the synapse","volume":"41","author":"Pilgram","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2741\/4532","article-title":"Trans-synaptic homeostasis at the myasthenic neuromuscular junction","volume":"22","author":"Plomp","year":"2017","journal-title":"Front. Biosci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.expneurol.2015.01.007","article-title":"Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models","volume":"270","author":"Plomp","year":"2015","journal-title":"Exp. Neurol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann. Neurol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hypersensitivity in patients with myasthenia gravis seropositive for MuSK antibody","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve"},{"key":"B201","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/gb-2013-14-9-213","article-title":"Neurexins","volume":"14","author":"Reissner","year":"2013","journal-title":"Genome Biol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1101\/gad.279745.116","article-title":"Diverging roles for Lrp4 and Wnt signaling in neuromuscular synapse development during evolution","volume":"30","author":"Rem\u00e9dio","year":"2016","journal-title":"Genes Dev."},{"key":"B203","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1749-6632.2012.06782.x","article-title":"Animal models of antimuscle-specific kinase myasthenia","volume":"1274","author":"Richman","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B204","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ncl.2018.01.004","article-title":"Muscle-specific tyrosine kinase and myasthenia gravis owing to other antibodies","volume":"36","author":"Rivner","year":"2018","journal-title":"Neurol. Clin."},{"key":"B205","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis","volume":"72","author":"Rodr\u00edguez Cruz","year":"","journal-title":"JAMA Neurol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1212\/wnl.0000000000001952","article-title":"Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes","volume":"85","author":"Rodr\u00edquez Cruz","year":"","journal-title":"Neurology"},{"key":"B207","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/brain\/awz107","article-title":"The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A mutations","volume":"142","author":"Rodr\u00edquez Cruz","year":"2019","journal-title":"Brain"},{"key":"B208","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/humu.23949","article-title":"Congenital myasthenic syndrome due to mutations in MuSK suggests that the level of MuSK phosphorylation is crucial for govering synaptic structure","volume":"41","author":"Rodr\u00edquez Cruz","year":"2020","journal-title":"Hum. Mutat."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/ijms19061677","article-title":"The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes","volume":"19","author":"Rodr\u00edguez Cruz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.matbio.2016.08.008","article-title":"The role of laminins in the organization and function of neuromuscular junctions","volume":"57","author":"Rogers","year":"2017","journal-title":"Matrix Biol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"474512","DOI":"10.4061\/2011\/474512","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis."},{"key":"B212","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000334862","article-title":"Serum levels of matrix metalloproteinases: implications in clinical neurology","volume":"67","author":"Romi","year":"2012","journal-title":"Eur. Neurol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fnagi.2014.00099","article-title":"Degeneration of neuromuscular junction in age and dystrophy","volume":"6","author":"Rudolf","year":"2014","journal-title":"Front. Aging Neursci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","article-title":"Ultrastructural localization of the terminal and lytic ninth complement (C9) at the motor end-plate in myasthenia gravis","volume":"39","author":"Sahashi","year":"1980","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1042\/bst20051295","article-title":"Retrograde signalling at the synapse: a role for Wnt proteins","volume":"33","author":"Salinas","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"B217","doi-asserted-by":"publisher","first-page":"e46663","DOI":"10.1371\/journal.pone.0046663","article-title":"Agrin and synaptic laminin are required to maintain adult neuromuscular junctions","volume":"7","author":"Samuel","year":"2012","journal-title":"PLoS One"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/ejn.12922","article-title":"Adenosine receptors and muscarinic receptors cooperate in acetylcholine release modulation in the neuromuscular synapse","volume":"42","author":"Santaf\u00e9","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-019-03273-1","article-title":"Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese adverse drug event report database","volume":"145","author":"Sato","year":"2019","journal-title":"J. Neurooncol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1083\/jcb.201107083","article-title":"Neuregulin\/ErbB regulate neuromuscular junction development by phosphorylation of \u03b1-dystrobrevin","volume":"195","author":"Schmidt","year":"2011","journal-title":"J. Cell Biol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"36835","DOI":"10.1074\/jbc.m607887200","article-title":"Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin","volume":"281","author":"Scotton","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B222","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamaneurol.2015.0853","article-title":"Impaired synaptic development, maintenance, and neuromuscular transmission in Lrp4-related myasthenia","volume":"72","author":"Selcen","year":"2015","journal-title":"JAMA Neurol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"e34625","DOI":"10.7554\/elife.34625","article-title":"Motoneuron Wnts regulate neuromuscular junction development","volume":"7","author":"Shen","year":"2018","journal-title":"Elife"},{"key":"B224","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J. Clin. Investig."},{"key":"B225","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tins.2012.04.005","article-title":"Molecular mechanisms underlying maturation and maintenance of the vertebrate neuromuscular junction","volume":"35","author":"Shi","year":"2012","journal-title":"Trends Neurosci."},{"key":"B226","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3988\/jcn.2014.10.2.119","article-title":"Clinical and electrophysiologic responses to acetylcholinesterase inhibitors in MuSK-antibody-positive myasthenia gravis: Evidence for cholinergic neuromuscular hypersensitivity","volume":"10","author":"Shin","year":"2014","journal-title":"J. Clin. Neurol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1523\/jneurosci.5778-09.2010","article-title":"Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction","volume":"30","author":"Simeone","year":"2010","journal-title":"J. Neurosci."},{"key":"B228","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fnmol.2018.00207","article-title":"BDNF-TrkB signaling coupled to nPKC\u03b5 and cPKC\u03b2I modulate the phosphorylation of the exocytotic protein Munc18\u20131 during synaptic activity at the neuromuscular junction","volume":"11","author":"Sim\u00f6","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/dneu.20953","article-title":"Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction","volume":"71","author":"Singhal","year":"2011","journal-title":"Dev. Neurobiol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.neuron.2016.08.013","article-title":"Genetic background limits generalizability genotype-phenotype relationships","volume":"91","author":"Sittig","year":"2016","journal-title":"Neuron"},{"key":"B231","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/mus.10294","article-title":"Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro","volume":"27","author":"Skeie","year":"2002","journal-title":"Muscle Nerve"},{"key":"B232","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jneuroim.2014.09.013","article-title":"Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy","volume":"276","author":"Skriapa","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1212\/wnl.59.1.92","article-title":"The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970\u20131999","volume":"59","author":"Somnier","year":"2002","journal-title":"Neurology"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3389\/fonc.2019.01055","article-title":"Clinicopathologic significance and immunogenomic analysis of programmed death-ligand 1 (PD-L1) and programmed death 1 (PD-1) expression in thymic epithelial tumors","volume":"9","author":"Song","year":"2019","journal-title":"Front. Oncol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuroscience.2005.11.040","article-title":"\u03b1-Neurexions are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction","volume":"138","author":"Sons","year":"2006","journal-title":"Neuroscience"},{"key":"B236","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/dneu.22138","article-title":"Postsynaptic assembly: a role for Wnt signaling","volume":"74","author":"Stamatakou","year":"2014","journal-title":"Dev. Neurobiol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1096\/fj.15-278739","article-title":"APTT-dependent glial cell line-derived neurotrophic gactor gene expression drives neuromuscular junction","volume":"30","author":"Stanga","year":"2016","journal-title":"FASEB J."},{"key":"B238","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2016.01.018","article-title":"Titin antibodies in \u201cseronegative\u201d myasthenia gravis-A new role for an old antigen","volume":"292","author":"Stergiou","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.str.2004.02.001","article-title":"Modulation of agrin function by alternative splicing and Ca2+ binding","volume":"12","author":"Stetefeld","year":"2004","journal-title":"Structure"},{"key":"B240","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jmb.2006.09.019","article-title":"Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK","volume":"364","author":"Stiegler","year":"2006","journal-title":"J. Mol. Biol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmb.2009.07.091","article-title":"Crystal structure of the Frizzled-like cycteine-rich domain of the receptor tyrosine kinase MuSK","volume":"393","author":"Stiegler","year":"2009","journal-title":"J. Mol. Biol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"e29976","DOI":"10.1371\/journal.pone.0029976","article-title":"Wnt4 participates in the formation of vertebrate neuromuscular junction","volume":"7","author":"Strochlic","year":"2012","journal-title":"PLoS One"},{"key":"B243","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2012.06.012","article-title":"The presynaptic active zone","volume":"75","author":"S\u00fcdhof","year":"2012","journal-title":"Neuron"},{"key":"B244","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/nyas.13560","article-title":"Pathophyusiological mechanisms of autoimmunity","volume":"1413","author":"Sudres","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B245","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jneuroim.2008.04.040","article-title":"Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis","author":"Takamori","year":"","journal-title":"J. Neuroimmunol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jneuroim.2008.06.001","article-title":"Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis","volume":"200","author":"Takamori","year":"","journal-title":"J. Neuroimmunol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1749-6632.2012.06784.x","article-title":"Structure of the neuromuscular junction: function and cooperative mechanisms in the synapse","volume":"1274","author":"Takamori","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B248","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1573395510666140318003732","article-title":"Structural and pathogenic mechanisms centered on muscle-specific tyrosine kinase in autoimmune neuromuscular junction disorders","volume":"9","author":"Takamori","year":"2013","journal-title":"Curr. Immunol. Rev."},{"key":"B249","doi-asserted-by":"publisher","first-page":"E896","DOI":"10.3390\/ijms18040896","article-title":"Synaptic homeostasis and its immunological disturbance in neuromuscular junction disorders","volume":"18","author":"Takamori","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B250","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21767\/2471-8513","article-title":"Pathogenic participation of MuSK-biglycan linkage contributive to synaptic stability and signaling in myasthenia gravis","volume":"3","author":"Takamori","year":"","journal-title":"J. Autoimmun. Disord."},{"key":"B251","doi-asserted-by":"publisher","first-page":"6","DOI":"10.29245\/2578-3009\/2019\/3.1173","article-title":"Synaptic compensatory mechanism and its impairment in autoimmune myasthenic diseases","volume":"3","author":"Takamori","year":"2019","journal-title":"J. Immunol. Sci."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1468-1331.2007.01931.x","article-title":"Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders","volume":"14","author":"Takamori","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1212\/01.wnl.0000125254.99397.68","article-title":"Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis","volume":"62","author":"Takamori","year":"2004","journal-title":"Neurology"},{"key":"B254","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneuroim.2012.09.001","article-title":"Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis","volume":"254","author":"Takamori","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0022-510x(88)90150-5","article-title":"Myasthenogenic significance of synthetic \u03b1-subunit peptide 183\u2013200 of Torpedo californica and human acetylcholine receptor","volume":"85","author":"Takamori","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"B256","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0022-510x(84)90013-3","article-title":"Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis","volume":"66","author":"Takamori","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"B257","doi-asserted-by":"publisher","first-page":"e127167","DOI":"10.1172\/jci.insight.127167","article-title":"Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients","volume":"4","author":"Takata","year":"2019","journal-title":"JCI Insight"},{"key":"B258","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mus.25597","article-title":"Rituximab treatment of myasthenia gravis: a systematic review","volume":"56","author":"Tandan","year":"2017","journal-title":"Muscle Nerve"},{"key":"B259","doi-asserted-by":"publisher","first-page":"16556","DOI":"10.1073\/pnas.1408409111","article-title":"The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses","volume":"111","author":"Tezuka","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B260","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4+CD25highCD127low\/- T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fphar.2018.00397","article-title":"Adenosine receptors in developing and adult mouse neuromuscular junctions and functional links with other metabotrophic receptor pathways","volume":"9","author":"Tom\u00e0s","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0165-5728(98)00092-7","article-title":"Identification of haemopoietic biglycan in hyperplastic thymus associated with myasthenia gravis","volume":"89","author":"Tomoyasu","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/mus.25969","article-title":"Autoimmune antibodies to collagen XIII in myasthenia gravis patients","volume":"57","author":"Tu","year":"2018","journal-title":"Muscle Nerve"},{"key":"B264","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Autoimmun. Res."},{"key":"B265","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1073\/pnas.85.9.2899","article-title":"Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67\u201376 of the \u03b1 subunit","volume":"85","author":"Tzartos","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B266","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B267","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1172\/JCI97911","article-title":"Neonatal Fc receptor antagonist Efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B268","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/08820139.2017.1299754","article-title":"Immunization with recombinantly expressed LRP4 induces experimental autoimmune myasthenia gravis in C57BL\/6 mice","volume":"46","author":"Ulusoy","year":"2017","journal-title":"Immunol. Invest."},{"key":"B269","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/wco.0000000000000736","article-title":"The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies","volume":"32","author":"Vanhaesebrouck","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1093\/brain\/awz322","article-title":"\u03b22-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure","volume":"142","author":"Vanhaesebrouck","year":"2019","journal-title":"Brain"},{"key":"B271","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"B272","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"40053","DOI":"10.18632\/oncotarget.5548","article-title":"LGR5 regulates pro-survival MEK\/ERK and proliferative Wnt\/\u03b2-catenin signaling in neuroblastoma","volume":"6","author":"Vieira","year":"2015","journal-title":"Oncotarget"},{"key":"B274","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis pateints","volume":"1413","author":"Villegas","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B276","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nyas.13592","article-title":"Serological and experimental studies in different forms of myasthenia gravis","volume":"1413","author":"Vincent","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B275","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp.43.7.590","article-title":"Anti-acetylcholine receptor antibodies","volume":"43","author":"Vincent","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B277","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1749-6632.2012.06789.x","article-title":"Antibodies identified by cell-based assays in myasthenia gravis and associated diseases","volume":"1274","author":"Vincent","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B278","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jneuroim.2010.10.024","article-title":"Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis","volume":"232","author":"Vrolix","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"21668","DOI":"10.1074\/jbc.m709939200","article-title":"Wnt\/\u03b2-catenin signaling suppresses rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B280","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1523\/jneurosci.3786-15.2016","article-title":"Reversible recruitment of a homeostatic reserve pool of synaptic vesicles underlies rapid homeostatic plasticity of quantal content","volume":"36","author":"Wang","year":"2016","journal-title":"J. Neurosci."},{"key":"B281","doi-asserted-by":"publisher","first-page":"10788","DOI":"10.1523\/jneurosci.2132-09.2009","article-title":"Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci."},{"key":"B282","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is critical for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"key":"B283","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.049","article-title":"Imbalance of circulating CD+CXCR5+FOXP3+ Tfr-like cells and CD+CXCR5+FOXP3\u2212 Tfh-like cells in myasthenia gravis","volume":"630","author":"Wen","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B284","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1023\/b:neur.0000020631.69804.f5","article-title":"Activity dependent removal of agrin from synaptic basal lamina by matrix metalloproteinase 3","volume":"32","author":"Werle","year":"2003","journal-title":"J. Neurocytol."},{"key":"B285","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of MGTX randmised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"e07266","DOI":"10.7554\/elife.07266","article-title":"Slit2 as a \u03b2-catenin\/Ctnnb1-dependent retrograde signal for presynaptic differentiation","volume":"4","author":"Wu","year":"2015","journal-title":"Elife"},{"key":"B287","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1242\/dev.080705","article-title":"\u03b2-catenin gain of function in muscles impairs neuromuscular junction formation","volume":"139","author":"Wu","year":"","journal-title":"Development"},{"key":"B288","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distict roles of muscle and motoneuron Lrp4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"","journal-title":"Neuron"},{"key":"B289","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To bild a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"Wu","year":"2010","journal-title":"Development"},{"key":"B2960","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135013","article-title":"Rapsyn as a signaling and scaffolding molecule in NMJ formation and maintenance","volume":"135013","author":"Xing","year":"2020","journal-title":"Neurosci. Lett."},{"key":"B290","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/bs.ctm.2015.07.002","article-title":"Molecular basis of laminin-integrin interactions","volume":"76","author":"Yamada","year":"2015","journal-title":"Curr. Top. Membr."},{"key":"B291","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2018.01.015","article-title":"Induction of anti-agrin antibodies causes myasthenia gravis in mice","volume":"373","author":"Yan","year":"","journal-title":"Neuroscience"},{"key":"B292","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/nyas.13573","article-title":"Agrin and Lrp4 antibodies as new biomarkers of myasthenia gravis","volume":"1413","author":"Yan","year":"","journal-title":"Ann. N Y Acad. Sci."},{"key":"B293","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nn.2747","article-title":"Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse","volume":"14","author":"Yang","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B294","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","volume":"57","author":"Yi","year":"2018","journal-title":"Muscle Nerve"},{"key":"B295","doi-asserted-by":"publisher","first-page":"ra87","DOI":"10.1126\/scisignal.aaf0890","article-title":"MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells","volume":"9","author":"Yilmaz","year":"2016","journal-title":"Sci. Signal."},{"key":"B296","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"},{"key":"B297","doi-asserted-by":"publisher","first-page":"e004911","DOI":"10.1101\/cshperspect.a004911","article-title":"Basement membranes: Cell scaffoldings and signaling platforms","volume":"3","author":"Yurchenco","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"40624","DOI":"10.1074\/jbc.m111.279307","article-title":"Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK)","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B298","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1756-6606-5-7","article-title":"Wnt proteins regulate acetylcholine receptor clustering in muscle cells","volume":"5","author":"Zhang","year":"","journal-title":"Mol. Brain"},{"key":"B302","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"","journal-title":"Arch. Neurol."},{"key":"B299","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1523\/JNEUROSCI.4691-06.2007","article-title":"\u03b2-catenin regulates acetylcholine receptor clustering in muscle cells through interaction with rapsyn","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."},{"key":"B300","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"Lrp4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"key":"B301","doi-asserted-by":"publisher","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"B303","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/dneu.22331","article-title":"Combination of agrin and laminin increase acetylcholine receptor clustering and enhance functional neuromuscular junction formation in vitro","volume":"76","author":"Zhang","year":"2015","journal-title":"Dev. Neurobiol."},{"key":"B2950","doi-asserted-by":"publisher","first-page":"3465\u20133477","DOI":"10.1523\/NEUROSCI.2934-16.2017","article-title":"Muscle Yap is a regulator of neuromuscular junction formation and regeneration","volume":"37","author":"Zhao","year":"2017","journal-title":"J. Neurosci."},{"key":"B305","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-Lrp4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J. Autoimmun."},{"key":"B306","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jns.2014.12.015","article-title":"Collagen Q-a potential target for autoantibodies in myasthenia gravis","volume":"348","author":"Zoltowska Katarzyna","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B307","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s00018-012-1209-9","article-title":"Structural mechanisms of the agrin-Lrp4-MuSK signaling pathway in neuromuscular junction differentiation","volume":"70","author":"Zong","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"B308","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1101\/gad.180885.111","article-title":"Structural basis of agrin-Lrp4-MuSK signaling","volume":"26","author":"Zong","year":"2012","journal-title":"Genes Dev."},{"key":"B309","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.nmd.2013.03.013","article-title":"Double seronegative myasthenia gravis with anti-LRP4 antibodies","volume":"23","author":"Zouvelou","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"B310","doi-asserted-by":"publisher","first-page":"10622","DOI":"10.1073\/pnas.1301277110","article-title":"Structure and superorganization of acetylcholine receptor-rapsyn complexes","volume":"110","author":"Zuber","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B311","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.autrev.2019.102366","article-title":"Next-generation Fc receptor-targeting biologics for autoimmune diseases","volume":"18","author":"Zuercher","year":"2019","journal-title":"Autoimmun. Rev."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2020.00086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T04:25:46Z","timestamp":1590726346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2020.00086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":314,"alternative-id":["10.3389\/fnmol.2020.00086"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2020.00086","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"article-number":"86"}}